跳至主要内容
临床试验/CTRI/2026/01/101465
CTRI/2026/01/101465尚未招募不适用

Correlation of PSA , MRI , TRUS Biopsy , PET- CT and RP Specimen findings in Carcinoma Prostate

未提供1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2026年2月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
45
试验地点
1

研究概览

简要总结

This study will include eligible patients attending the department of Urology, Narayana Health City, Bangalore for the evaluation and management of carcinoma prostate, who consent to be part of the study.   Data on patient demographics, comorbidities, PSA levels, MRI PI-RADS scores, TRUS biopsy results, PET-CT findings, and radical prostatectomy (RP) specimen pathology results will be collected using a standardized proforma.

The primary objective is to analyze  is there a correlation between MRI Findings  / TRUS Biopsy of prostate and PSMA PET -CT findings in patient with abnormal PSA and finally co relate with Radical prostatectomy specimen

研究设计

研究类型
Observational

入排标准

年龄范围
50.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients with histologically confirmed prostate adenocarcinoma.
  • Patients who have undergone Serum PSA testing within 1-3 months prior to imaging or biopsy, MRI with PI-RADS scoring, TRUS-guided biopsy,PET-CT and Radical Prostatectomy with histopathological examination of specimens.
  • Patients with localized or locally advanced disease (cT1–T3).
  • Patients with confirmed distant metastases (e.g., M1 stage).
  • Patients aged 50–80 years with ECOG Performance Status of 0–
  • Patients who have not undergone any prior treatment for prostate cancer (e.g., androgen deprivation therapy, chemotherapy, or radiation therapy).
  • Patients who provide written informed consent for participation and data usage in the study.

排除标准

  • Patients who have received prior surgical, radiation, or pharmacological treatment for prostate cancer.

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Patan Saif Khan

Narayana Health

研究点 (1)

Loading locations...

相似试验